Translational Pathways for Cardiovascular Devices – Session III: Current Challenges and Future Direction for Mitral/Tricuspid Valve Device Development and Iteration – FDA Point of View Practice Quiz
Time limit: 0
Quiz Summary
0 of 3 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Quiz complete. Results are being recorded.
Results
Time has elapsed
Categories
Not categorized0%
You have completed the practice quiz, please continue on to the next session.
1
2
3
Current
Review
Answered
Correct
Incorrect
Question 1 of 3
1. Question
The average 10 year survival of patients who are over 65 years of age and undergoes isolated surgical mitral valve repair for primary mitral regurgitation is?
Correct
Incorrect
Question 2 of 3
2. Question
The recurrence rate in patients who undergo isolated surgical mitral valve repair for primary MR is high if:
Correct
Incorrect
Question 3 of 3
3. Question
A new device for the treatment of primary mitral regurgitation is undergoing clinical trial evaluation. Which of the following is correct regarding the comparator?